文献库搜索 | GeneLibs

Naskar(N),Kumar(S),Mamgai(D),Vishwakarma(H... Mol Divers 2026-08-00

...PIK3CA, PIK3CB, PIK3CD, PIK3R2, PLCG1, JAK2, IGF1R, ZAP70, and ERBB4), several of which are key regulators of the PI3K-A...

Al-Hussaini(M),Al Sharie(S),Azzam(S),Erash... Clin Neuropathol None

...PIK3CA genes, and a variant mutation of unknown significance (VUS) involving the PDGFRA gene. DNA methylation profiling ...

Cetin(B),Erdem(D),Karaman(I),Gumusay(O) Curr Treat Options Oncol 2026-04-18

...PIK3CA–AKT–PTEN pathway, treatment selection is similarly biomarker driven. In patients with PIK3CA mutations, fulvestra...

De Angelis(C),de Biase(D),Gerratana(L),Arp... Breast 2026-06-00

...PIK3CA has gained therapeutic relevance, guiding the use of PIK3CA-targeted inhibitors such as alpelisib and inavolisib....

Zhang(G),Shu(W),Li(H),Zhang(C),Wang(X),Li(... Pathol Res Pract 2026-06-00

...PIK3CA, which in turn suppressed the PI3K/AKT signaling pathway, finally suppressing inflammatory responses and inhibiti...

Bello(O),Rieur(O),Vidula(N) Pharmacogenomics None

...PIK3CA, ESR1, ERBB2, BRCA1/2, and AKT/PTEN are reviewed in relation to their corresponding therapeutic agents. Implement...

Peng(J),Ma(Y),Mai(J),Xie(J),Chen(S),Wei(J)... Comb Chem High Throughput S... 2026-04-14

...PIK3CA, AKT1 targets and regulating PI3K-Akt, MAPK signaling pathways. The compatibility of different functional units c...

Nagano(H),Kiyama(S),Kyutoku(T),Matsumoto(H... Otolaryngol Pol 2026-03-19

...PIK3CA (28.0%), NOTCH3 (19.8%), LTK (18.4%), CDKN2A (...

Zhang(Z),Zhan(S),Tang(Y),Ling(Z),Wu(J),Rui... Hum Mutat None

...PIK3CA (8.2%) as the most frequently mutated genes. EGFR-mutant tumors exhibited significantly higher CEA levels (p = 0....

Suryavanshi(M),Ostwal(V),Javle(M),Kumar(M)... BMC Cancer 2026-04-20

...PIK3CA (9.4%). Compared to international cBioPortal data, the Indian cohort showed significantly elevated TP53 (35.8% vs...